Teva Pharma (TEVA) PT Raised to $26 at UBS
Tweet Send to a Friend
(Updated - September 3, 2024 9:33 AM EDT)
UBS analyst Ashwani Verma raised the price target on Teva Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Ashwani Verma raised the price target on Teva Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
